IL-33 produced by M2 macrophages promoted Th2 cytokine production via IL-33 receptor activation and contributed to Th2-dominant pathophysiology in IgG4-RD [37]. This evidence concerns the gene IL33 and immunoglobulin G4-related sclerosing disease.